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Multiple sclerosis (MS) is the commonest disease of the
central nervous system (CNS) to cause permanent disability
inyoungadults.Basedonstrongcircumstantialevidence,MS
is considered to be an organ-speciﬁc autoimmune disorder,
but the exact cause is as yet unknown. It appears that the
disease develops in a genetically susceptible population as a
result of environmental exposures.
The incidence of MS has been documented to be
increasing across the globe. The focus of this issue was
therefore on studies with a goal of further understanding
the aetiology of the disease. We were pleased to have
received submissions on a wide variety of topics including
the immunology of MS (research papers on the roles of
Fc receptors by X. Z. Hu et al. and tumor necrosis factor-
(TNF-) related apoptosis-inducing ligand (TRAIL) by A. L.
O. Hebb and colleagues) and the genetics and epigenetics
of MS (reviews on the future of MS genetics by S. V.
Ramagopalan and D. A. Dyment and microRNAs in MS by
K. U. Tufekci and coworkers). The potential role of vitamin
D deﬁciency inﬂuencing susceptibility to and the clinical
course of MS is gaining interest, and to this end, we have a
reviewpaperonthistopicbyJ.Smoldersandaresearchpaper
describing the novel role of a vitamin D receptor modulator
on experimental autoimmune encephalomyelitis by S. Na et
al. The role of mitochondria as potentially underlying CNS
damage is reviewed by G. R. Campbell and D. J. Mahad,
and J. Witherick and colleagues review a potential treatment
measure, namely, mesenchymal stem cells. Finally, we have
a perspective piece regarding the potential role of human
endogenousretrovirusesinMSbyB.KroneandJ.M.Grange,
and ﬁnally G. Disanto and colleagues try to address the
complex issue of heterogeneity of multiple sclerosis.
Wehopethatyouenjoyreading thisspecial issueas much
as we enjoyed putting it together.
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